Cargando…
Excellent survival in relapsed stage I testicular cancer
BACKGROUND: Two thirds of patients with germ-cell cancer (GCC) present as clinical stage I (CSI). Following orchiectomy, active surveillance (AS) has become their standard management. However, 15–50% of patients eventually relapse with metastatic disease after AS. Relapses need to be detected early...
Autores principales: | Speicher, Philip, Fankhauser, Christian D., Lorch, Anja, Ardizzone, Davide, Helnwein, Simon, Hoch, Dennis, Hermanns, Thomas, Beyer, Jörg, Akhoundova, Dilara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503206/ https://www.ncbi.nlm.nih.gov/pubmed/37715132 http://dx.doi.org/10.1186/s12885-023-11388-y |
Ejemplares similares
-
Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report
por: Hoch, Dennis, et al.
Publicado: (2023) -
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
por: Christiansen, Ailsa J., et al.
Publicado: (2022) -
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data
por: Grogg, Josias Bastian, et al.
Publicado: (2020) -
Is conservative management safe in patients with acute ureterolithiasis and perirenal stranding?
por: Grossmann, Nico C., et al.
Publicado: (2023) -
Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)